Products for Research Use Only
RegisterLogin

Belantamab (FUT8-KO)

CAT: 0804-HY-P9980A-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9980A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Belantamab (FUT8-KO) is an anti-BCMA (TNFRSF17) monoclonal antibody expressed by CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Fucose deficiency enhances the ADCC effect of the antibody. Belantamab (FUT8-KO) can be used to synthesize antibody-active molecule conjugate (ADC), Belantamab mafodotin[1].
UNSPSC
12352203
Target
ADC Antibody; TNF Receptor
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.10
Smiles
[Belantamab(FUT8-KO)]
Molecular Weight
(146.06 kDa)
References & Citations
[1]Ivo Demel, et al. Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021. Br J Haematol. 2021 May;193 (4) :705-722.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P990902AAtigotatug (FUT8-KO)
HY-P9977A-01Amivantamab (FUT8-KO)
HY-P99295AImgatuzumab (FUT8-KO)
HY-P9991AOsemitamab (FUT8-KO)
HY-P99653A-01Ianalumab (FUT8-KO)
HY-P99113A-01Inebilizumab (FUT8-KO)
HY-P99406A-01Petosemtamab (FUT8-KO)
HY-P99010A-01Bemarituzumab (FUT8-KO)
HY-P9980-01Belantamab
HY-P3239-01Belantamab mafodotin

Alternative Products

CatalogName
T9901A-824-01Belantamab (FUT-8 KO)
GTR18679009-01Belantamab (FUT-8 KO) Antibody
T9901A-934-01Osemitamab (FUT8-KO)
T9901A-491-01Bemarituzumab (FUT8-KO)
T9901A-486-01Petosemtamab (FUT8-KO)
T9901A-130-01Inebilizumab (FUT8-KO)
T9901A-236-01Ianalumab (FUT8-KO)
T9901A-1662-01Atigotatug (FUT8-KO)
T9901A-232-01Amivantamab (FUT8-KO)
GTR18612696-01Petosemtamab (FUT8-KO) Antibody

Popular Products